Background and Purpose-Collaterals sustain the penumbra before recanalization and offset infarct growth, yet the influence of baseline collateral flow on recanalization after endovascular therapy remains relatively unexplored. Methods-We analyzed consecutive patients who received endovascular therapy for acute cerebral ischemia from 2 distinct study populations. 
I
n the setting of acute ischemic stroke, arterial revascularization to restore antegrade perfusion to the ischemic territory remains the principal therapeutic approach. Although the pathophysiological recruitment of cerebral collateral circulation in the setting of chronic hemodynamic insufficiency has been explored, 1 relatively little attention has been devoted to the role of pretreatment collateral circulation in patients with acute ischemic stroke who are candidates for recanalization therapy. 2, 3 In a previous transcranial Doppler study of a small series with acute stroke, early recanalization of embolic middle cerebral artery (MCA) occlusions within up to 8 hours, in conjunction with good transcortical collateralization, has a favorable impact on infarct size and outcome. 4 A retrospective CT-based volumetric analysis reported that infarct volume and clinical severity at discharge were lower for patients with better pretreatment pial collateral formation. 5 A recent perfusion-diffusion MRI-based study has shown that angiographic collateral grade and penumbral volume interactively shape tissue fate in patients undergoing endovascular recanalization therapy. 6 However, the relationship between baseline collateral flow and the rate of revascularization remains unknown.
In the present study, we evaluated the relationship between baseline angiographic collaterals and recanalization after endovascular therapy. For external validation, we compared the data from 2 study populations in which the mode of revascularization therapy differs. In addition, we assessed the infarct growth on serial MRI. Patients were included in this study if (1) they presented with symptoms of acute cerebral ischemia within the MCA territory; and (2) they underwent conventional angiography for endovascular therapy. The local Institutional Review Boards approved the study.
Angiography
All patients underwent comprehensive diagnostic cerebral angiography, including injection of both internal carotid arteries and the dominant vertebral artery, with assessment through the late venous phase to assess collateral flow from all possible sources. Angiographic collateral grade was evaluated with the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) Collateral Flow Grading System on pretreatment angiography. 7 This angiographic scale assigns patients to Grade 0 (no collaterals visible to the ischemic site), 1 (slow collaterals to the periphery of the ischemic site with persistence of some of the defect), 2 (rapid collaterals to the periphery of ischemic site with persistence of some of the defect and to only a portion of the ischemic territory), 3 (collaterals with slow but complete angiographic blood flow of the ischemic bed by the late venous phase), and 4 (complete and rapid collateral blood flow to the vascular bed in the entire ischemic territory by retrograde perfusion). Vascular reperfusion was based on the Thrombolysis In Myocardial Infarction (TIMI) scale with assignments of 3 (complete recanalization), 2 (partial recanalization), 1 (minimal recanalization), and 0 (no recanalization). Two reviewers independently assessed the pretreatment collateral grade and TIMI scale. Kappa coefficient for interobserver agreement was 0.896 for collateral grade and 0.79 for TIMI grade. The opinion of a third neuroradiologist was sought to resolve disagreements. The authors were blinded to the patient information through the processes.
Diagnostic Evaluation
All patients underwent routine blood tests, electrocardiography, cardiac telemetry for at least 24 hours, and echocardiography. All patients underwent MRI before revascularization therapy if not contraindicated. Diffusion-weighted imaging lesion volume measurements were performed by 1 of the authors blinded to the clinical information. For each patient, diffusion-weighted imaging lesion volumes were outlined automatically with subsequent manual correction and volumes were calculated with a computer-assisted volumetric analysis program (Medical Image Processing, Analysis and Visualization, Version 2.1, CIT, National Institutes of Health).
Statistical Analysis
Continuous data are shown as meanϮSD, whereas categorical variables are presented as absolute and relative frequencies. We analyzed the differences between the groups using the Pearson 2 test or a linear-by-linear association for categorical variables, and a Student t test, a 1-way analysis of variance, or Kruskal-Wallis test for continuous variables. Spearman correlation coefficient was used to analyze the association of collateral grade with the degree of infarct growth. In addition, independent factors for a patient having a good recanalization were evaluated using a logistic regression. In this study, a score of 0 to 1 was designated as poor and 2 to 3 as good (therapeutic) recanalization. Age, gender, atrial fibrillation, time from onset of symptoms to endovascular therapy, site of occlusion, the National Institutes of Health Stroke Scale score on admission, the mode of endovascular therapy, intravenous tissue plasminogen activator (tPA) before endovascular therapy, and pretreatment collateral grade all served as predictor variables. Variables from univariate analyses at PϽ0.2 were considered to represent explanatory variables and were evaluated together by multivariate analysis. All statistical analyses were performed using commercially available software (SPSS for Windows, Version 13.0; SPSS Inc, Chicago, IL). PϽ0.05 was considered statistically significant.
Results

Patient Characteristics
A total of 222 patients was included, 138 from the United States and 84 from South Korea. Baseline characteristics for the US and South Korean subjects are listed in Table 1 . The National Institutes of Health Stroke Scale score on admission was lower in the South Korean subjects compared with the US subjects. Most US subjects received endovascular thrombectomy (93 of 138 patients) and the rest of the patients received intra-arterial fibrinolytics or other endovascular therapy. On the contrary, 28 South Korean subjects received intra-arterial fibrinolytics alone and 53 patients received other endovascular therapy with or without intra-arterial fibrinolytics. The time from last known well to the onset of endovascular therapy was shorter in the South Korean subjects compared with the US subjects (Pϭ0.001). South Korean subjects more frequently received tPA before endovascular therapy than the US subjects (PϽ0.001).
Factors Affecting Revascularization Rates
Patient characteristics depending on the treatment response (TIMI scale) are illustrated in Table 2 . Complete recanalization (TIMI 3) occurred in 54 patients, 87 patients showed partial recanalization (TIMI 2), and 81 poor recanalization (TIMI 0 to 1). Patients with greater extent of pretreatment collaterals more frequently achieved therapeutic recanalization. Among patients with poor pretreatment collateral grading (0 to 1 scores), complete recanalization (TIMI 3) was achieved in only 14.1% (11 of 78) patients, whereas it was observed in 25.2% (26 of 103) patients with good collaterals (2 to 3 score) and 41.5% (17 of 41) patients with excellent collaterals (4 score; PϽ0.001). This relationship was consistently observed in both study populations, although the mode of endovascular therapy was greatly different between them (Figure 1 ). When the analysis was performed separately in the US and South Korean subjects, this association remained significant (P for trendϭ0.001 for the US subjects and P for trendϭ0.045 for the South Korean subjects).
However, recanalization rate was not different depending on the mode of treatment. In addition, no association was found between intravenous tPA use before endovascular treatment and recanalization rate. Age/gender, atrial fibrillation, and National Institutes of Health Stroke Scale score on admission were not different depending on the TIMI score.
Because the recanalization rate may differ depending on the site of occlusion and the mode of treatment, subgroup analyses were performed. The relationship between the collateral grade and TIMI score were consistent observed in patients with internal carotid artery occlusion and MCA occlusion (P for trendϭ0.012 for internal carotid artery occlusion and P for trendϭ0.008 for MCA occlusion; Figure  2A -B). The same is true for patients who received Merci mechanical clot retrieval (nϭ93); the degree of recanalization differed depending on the pretreatment collateral grading, although patients received the same treatment modality (Pϭ0.002; Figure 2C ).
Multiple regression analysis was performed to further evaluate independent predictors for therapeutic recanalization (TIMI 2 to 3; Table 3 ). Pretreatment collateral grade was independently associated with recanalization rate, adjusting 
Discussion
Heterogeneity of Collateral Status in Acute Stroke
Collateral status differs among patients with acute ischemic stroke. 6, 8 Some patients may have excellent collaterals, whereas others may show poor collaterals. Despite these influential aspects of collateral flow, collaterals at angiography are often only considered as an interesting curiosity and are not typically used for decision-making in endovascular management. 3 In clinical practice, stroke neurologists or interventionalists often do not pay attention to the pretreatment collateral status or they tend to restore antegrade flow more aggressively if patients who have poor retrograde filling through collaterals.
The main findings of this study are that (1) pretreatment collaterals greatly influence the recanalization rate after endovascular therapy; and (2) favorable responses may not be expected after therapeutic recanalization in patients with poor collaterals.
Pretreatment Collateral Status and Recanalization Rate
Revascularization restoring antegrade flow is crucial for a favorable outcome in patients undergoing revascularization therapy. Final recanalization status represents a strong predictor of clinical outcomes in meta-analysis 9 and recent pooled analysis of thrombectomy trials. 10 The more aggressive and faster treatment may result in better recanalization. New revascularization modalities with a higher revascularization rate such as a suction device are now under development. However, collateral status was not considered in previous studies of endovascular therapy. Our data showed that the collateral status was the strongest predictor for therapeutic revascularization. On the contrary, the mode of endovascular therapy, prior use of intravenous tPA, and the time from onset to endovascular therapy were not independently associated with the recanalization rate. The strength of our study is rooted in our analyses from 2 centers evaluating distinct study populations to control for therapeutic modes. In addition, our results showed that the relationship between pretreatment collaterals and TIMI score was consistently observed when the site of occlusion and mode of endovascular treatment were considered.
There may be several explanations for better recanalization in patients with good collaterals. First, retrograde collateral filling may allow thrombolytic and neuroprotective agents (extrinsic, intrinsic, or both) access to distal aspects of clot. 11 Robust collaterals may also be important for dissolution of fragmented proximal thrombi. Second, besides the enhanced delivery of fibrinolytics agents to the occlusion site, other beneficial mechanisms of retrograde collateral flow may exist. Our previous results illustrate that collaterals and perfusion-diffusion mismatch represent related yet distinct aspects of ischemic pathophysiology. 6 Our present results showed that the recanalization rate was higher in patients who showed good collaterals and received mechanical revascularization therapy (Merci clot retrieval). During focal cerebral ischemia, cerebral blood vessel damage occurs early and in a progressive fashion. 12 The degree of ischemic vascular injury can be minimized by collateral supply to vessels as well as brain tissue within the oligemic regions; thus, the response to endovascular therapy could be augmented in patients with good collaterals. The importance of pharmacological agents designed to protect the vasculature has been suggested. 13 Further studies about the role of collaterals on vascular protection are warranted.
Our results are in good agreement with previous studies, which showed a correlation between pretreatment perfusion status and recanalization rates. 14, 15 Higher blood flow values in the affected hemisphere assessed by xenon-CT were the predictors of recanalization in patients with proximal MCA occlusion treated with intra-arterial thrombolysis. 14 In the present study, the perfusion status assesses at the time of endovascular treatment through a collateral grading score. Our results suggest the possibility of selecting patients for endovascular therapy based on perfusion information derived from collateral assessment obviating the need for other time-consuming tests.
Achieving Therapeutic Recanalization in Patients With Poor Collaterals
Revascularization is the main strategy of acute ischemic stroke, and a favorable outcome can be expected only in 
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recanalized patients. However, not all patients with therapeutic revascularization showed a favorable outcome. 10 A recent review showed that despite higher rates of recanalization, the mechanical thrombectomy studies have demonstrated substantially lower rates of good outcomes compared with intravenous and/or intra-arterial thrombolytic trials. 16 Such analyses disregard important differences in clot location and burden, baseline stroke severity, time from stroke onset to treatment, and patient selection in these studies. 16 Our results showed that recanalization despite poor collaterals may result in unexpected results. We have previously reported that pretreatment collateral grade may influence the severity of ischemic injury over the hypoperfused region and is associated with infarct growth. 6 Collaterals have previously been shown to be potentially more important than recanalization in some cases; poor collaterals are an important determinant, irrespective of the degree of recanalization. 5, 6 Chronic mild reduction of cerebral perfusion pressure induces ischemic tolerance in focal cerebral ischemia. 17 A smaller infarct growth within hypoperfused region in patients with good collaterals may be due to ischemic preconditioning. In the present study, infarct growth was not correlated with TIMI score in patients with poor collaterals. Moreover, when revascularization was achieved, more frequent symptomatic hemorrhagic transformation occurred in patients with poor collaterals than in those with good collaterals (data not shown). A higher frequency of infarct growth and symptomatic hemorrhagic transformation in patients with poor collaterals in whom therapeutic recanalization was achieved may support the concept of reperfusion injury.
A recent guideline for the early management of ischemic stroke recommended that unlike intravenous use of tPA in patients within the therapeutic time window, the use of intra-arterial fibrinolytics or endovascular therapy should be used in selected patients. 18 Thus, a personalized approach is needed. Our data raise the possibility that although patients who showed a baseline poor collateral are expected to have an unfavorable outcome, the efforts toward revascularization may not be beneficial and may even be harmful. In the present study, when complete recanalization was not achieved, infarct growth was usually not observed if good collaterals were noted.
Limitations
The results of this study should be interpreted with caution because this study is not a randomized controlled trial. Patients were treated with a variety of revascularization therapies, including fibrinolytics and various types of endovascular therapy. However, the association between pretreatment collaterals and the degree of recanalization was consistently observed regardless of the treatment modality and the site of occlusion. In addition, our data do not provide the answer to the question about what we should do for patients with poor collaterals. In cases collateral flow is marginal, evolving hemodynamic strategies to improve ischemia through augmentation of collateral perfusion may be warranted. 19 Therapeutic strategies enhancing collaterals may ultimately be as important as recanalization. Infarct growth may be minimized with the use of collateral therapeutic strategies, particularly in the setting of persistent arterial occlusion despite attempted recanalization. Collateral therapeutics may entail use of readily available hemodynamic manipulations such as head positioning, hypervolemia, hypertensive therapy, or partial aortic obstruction in selected cases. 19 Considering that recanalization is often achieved in only a fraction of cases undergoing endovascular therapy, further research on collateral circulation and related therapeutic approaches is warranted.
Conclusions
Our data indicated that a personalized approach is needed to maximize the effect of endovascular therapy. Angiographic collaterals should be considered individually in such patients, and the decision for more aggressive endovascular treatment should be tailored with the information of angiographic collateral status. Absence or relative paucity of collaterals may be used to predict unlikely recanalization despite aggressive therapeutic endovascular strategies. Alternatively, the presence of robust collateral flow at angiography may persuade clinicians to attempt further recanalization efforts, because collateral flow may be a marker for eventual success of such approaches. Our findings support the inclusion of collateral status in future efficacy trials of endovascular therapy. 3  0  24  2  0  0  2  87  1  10  UCLA  1  8  0  3  4  0  2  24  0  11  UCLA  4  0  20  2  2  3  0  1  77  0  12  UCLA  1  0  7  0  1  5  0  1  64  0  13  UCLA  3  0  10  2  4  0  1  62  1  14  UCLA  1  0  24  3  3  1  0  1  90  0  15  UCLA  3  0  14  0  3  0  2  73  0  16  UCLA  3  0  23  0  3  4  0  2  60  0  17  UCLA  1  0  4  2  3  0  1  88  1  18  UCLA  1  0  5  2  2  4  0  1  59  0  19  UCLA  1  0  16  2  1  1  0  1  53  0  20  UCLA  4  0  19  1  3  3  0  2  59  0  21  UCLA  4  0  19  1  2  4  0  1  76  1  22  UCLA  1  0  28  1  2  0  2  77  1  23  UCLA  1  0  17  2  1  0  1  81  1  24  UCLA  4  0  6  1  2  2  1  2  55  0  25  UCLA  1  0  7  2  2  4  0  2  79  0  26  UCLA  3  0  10  2  4  4  0  2  45  1  27  UCLA  1  0  20  0  3  0  1  88  0 
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